Chalcones against the hallmarks of cancer: a mini-review

References

• Abu N, Akhtar MN, Yeap SK, Lim KL, Ho WY, Abdullah MP, Ho CL, Omar AR, Ismail J, Alitheen NB. 2016. Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro. BMC Complement Altern Med. 16(1):1–14.
   PubMedGoogle Scholar
• Abu N, Mohamed NE, Yeap SK, Lim KL, Akhtar MN, Zulfadli AJ, Kee BB, Abdullah MP, Omar AR, Alitheen NB. 2015. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice. Drug Des Devel Ther. 9:1401–1417.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Kimmelman AC, Debnath J. 2019. Targeting autophagy in cancer: Recent advances and future directions. Cancer Discovery. CD-19-0292.
   Web of Science ®Google Scholar
• Arora L, Pal D. 2021. Remodeling of stromal cells and immune landscape in microenvironment during tumor progression. Front Oncol. 11:596798.
   PubMed Web of Science ®Google Scholar
• Bortolotto LFB, Barbosa FR, Silva G, Bitencourt TA, Beleboni RO, Baek SJ, Marins M, Fachin AL. 2017. Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest. Biomed Pharmacother. 85:425–433.
   PubMed Web of Science ®Google Scholar
• Carneiro BA, El-Deiry WS. 2020. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 17(7):395–417.
   PubMed Web of Science ®Google Scholar
• Celentano A, Yiannis C, Paolini R, Zhang P, Farah CS, Cirillo N, Yap T, McCullough M. 2020. Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro. Sci Rep. 10(1):1–11..
   PubMed Web of Science ®Google Scholar
• Chen HY, Huang TC, Shieh TM, Wu CH, Lin LC, Hsia SM. 2017. Isoliquiritigenin induces autophagy and inhibits ovarian cancer cell growth. Int J Mol Sci. 18(10):2025.
   PubMed Web of Science ®Google Scholar
• Chen C, Shenoy AK, Padia R, Fang D, Jing Q, Yang P, Su S-B, Huang S. 2018. Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-tetrahydroxychalcone. J Exp Clin Cancer Res. 37(1):1–14.
   PubMedGoogle Scholar
• Chen H, Shi D, Niu P, Zhu Y, Zhou J. 2018. Anti-inflammatory effects of cardamonin in ovarian cancer cells are mediated via mTOR suppression. Planta Med. 84(16):1183–1190.
   PubMed Web of Science ®Google Scholar
• Das M, Manna K. 2016. Chalcone scaffold in anticancer armamentarium: a molecular insight. J Toxicol. 2016:7651047.
   PubMed Web of Science ®Google Scholar
• DeVita VT, Rosenberg SA. 2012. Two hundred years of cancer research. N Engl J Med. 366(23):2207–2214.
   PubMed Web of Science ®Google Scholar
• Di S, Fan C, Ma Z, Li M, Guo K, Han D, Li X, Mu D, Yan X. 2019. PERK/eif-2α/CHOP pathway dependent ROS generation mediates butein-induced non-small-cell lung cancer apoptosis and G2/M phase arrest. Int J Biol Sci. 15(8):1637–1653.
   PubMed Web of Science ®Google Scholar
• Dillekås H, Rogers MS, Straume O. 2019. Are 90% of deaths from cancer caused by metastases? Cancer Med. 8(12):5574–5576.
   PubMed Web of Science ®Google Scholar
• Engelsgjerd S, Kunnimalaiyaan S, Kandil E, Clark Gamblin T, Kunnimalaiyaan M. 2019. Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines. PLoS One. 14(3):1–15.
   Web of Science ®Google Scholar
• Gan FF, Zhang R, Ng HL, Karuppasamy M, Seah W, Yeap WH, Ong SM, Hadadi E, Wong SC, Chui WK, et al. 2018. Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-κB signaling pathway. Food Chem Toxicol. 116:238–248.
   PubMed Web of Science ®Google Scholar
• Gomes MN, Muratov EN, Pereira M, Peixoto JC, Rosseto LP, Cravo PVL, Andrade CH, Neves BJ. 2017. Chalcone derivatives: promising starting points for drug design. Molecules. 22(8):1210.
   PubMed Web of Science ®Google Scholar
• Gong Y, Crawford JC, Heckmann BL, Green DR. 2019. To the edge of cell death and back. Febs J. 286(3):430–440.
   PubMed Web of Science ®Google Scholar
• Haiyan CAO, Xiude QIN, Chen LIU, Xinzhe Z, Yuhui MA, Jingna Z, Yu LIU, Shaoqin GE, Guowei Z, Hailiang NIE. 2020. Establishment of fluorescence sensitization method for Hydroxysafflor yellow A. Evidence-Based Complement Altern Med. 2020
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell. 144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT, Tew KD. 2020. Oxidative stress in cancer. Cancer Cell. 38(2):167–197.
   PubMed Web of Science ®Google Scholar
• Heng WS, Cheah SC. 2021. Identification of phytochemical-based β-catenin nuclear localization inhibitor in NSCLC: differential targeting population from member of isothiocyanates. Molecules. 26(2):399.
   PubMed Web of Science ®Google Scholar
• Hinshaw DC, Shevde LA. 2019. The tumor microenvironment innately modulates cancer progression. Cancer Res. 79(18):4557–4566.
   PubMed Web of Science ®Google Scholar
• Hong SH, Cha HJ, Hwang-Bo H, Kim MY, Kim SY, Ji SY, Cheong J, Park C, Lee H, Kim GY, et al. 2019. Anti-proliferative and pro-apoptotic effects of licochalcone a through ROS-mediated cell cycle arrest and apoptosis in human bladder cancer cells. Int J Mol Sci. 20(15):1–16.
   Web of Science ®Google Scholar
• Hou S, Yuan Q, Yu N, Liu B, Huang G, Yuan X. 2019. Cardamonin attenuates chronic inflammation and tumorigenesis in colon. Cell Cycle. 18(23):3275–3287.
   PubMed Web of Science ®Google Scholar
• Hsu YK, Chen HY, Wu CC, Huang YC, Hsieh CP, Su PF, Huang YF. 2021. Butein induces cellular senescence through reactive oxygen species-mediated p53 activation in osteosarcoma U-2 OS cells. Environ Toxicol. 36(5):773–781.
   PubMed Web of Science ®Google Scholar
• Huang W-C, Su H-H, Fang L-W, Wu S-J, Liou C-J. 2019. Licochalcone A inhibits cellular motility by suppressing E-cadherin and MAPK signaling in breast cancer. Cells. 8(3):218.
   PubMed Web of Science ®Google Scholar
• Huang XB, Yuan LW, Shao J, Yang Y, Liu Y, Lu JJ, Chen L. 2020. Cytotoxic effects of flavonoids from root of Sophora flavescens in cancer cells. Nat Prod Res. 13:1–6. doi:10.1080/14786419.2020.1712382.
   Google Scholar
• Ibarra-Berumen J, Rosales-Castro M, Ordaz-Pichardo C. 2021. Potential use of wood metabolites for cancer treatment. Nat Prod Res. 30:1–17. doi:10.1080/14786419.2021.1972420.
   Google Scholar
• Irfan R, Mousavi S, Alazmi M, Saleem RSZ. 2020. A comprehensive review of aminochalcones. Molecules. 25(22):5381.
   PubMed Web of Science ®Google Scholar
• Iwashina T. 2000. The structure and distribution of the flavonoids in plants. J Plant Res. 113(3):287–299.
   Google Scholar
• James S, Aparna JS, Paul AM, Lankadasari MB, Mohammed S, Binu VS, Santhoshkumar TR, Reshmi G, Harikumar KB. 2017. Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression. Sci Res. 7(1):1–16.
   Google Scholar
• Jandial DD, Krill LS, Chen L, Wu C, Ke Y, Xie J, Hoang BH, Zi X. 2017. Induction of G2M arrest by flavokawain a, a kava chalcone, increases the responsiveness of HER2-overexpressing breast cancer cells to herceptin. Molecules. 22(3):462.
   PubMed Web of Science ®Google Scholar
• Jantan I, Bukhari SNA, Adekoya OA, Sylte I. 2014. Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines. Drug Des Devel Ther. 8:1405–1418.
   PubMed Web of Science ®Google Scholar
• Jia D, Tan Y, Liu H, Ooi S, Li L, Wright K, Bennett S, Addison CL, Wang L. 2016. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo. Oncotarget. 7(1):771–785.
   PubMedGoogle Scholar
• Jiang CH, Sun TL, Xiang DX, Wei SS, Li WQ. 2018. Anticancer activity and mechanism of xanthohumol: a prenylated flavonoid from hops (Humulus lupulus L.). Front Pharmacol. 9:530.
   PubMed Web of Science ®Google Scholar
• Jin J, Qiu S, Wang P, Liang X, Huang F, Wu H, Zhang B, Zhang W, Tian X, Xu R, et al. 2019. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming. J Exp Clin Cancer Res. 38(1):1–16.
   PubMed Web of Science ®Google Scholar
• Kang TH, Seo JH, Oh H, Yoon G, Chae JI, Shim JH. 2017. Licochalcone A suppresses specificity protein 1 as a novel target in human breast cancer cells. J Cell Biochem. 118(12):4652–4663.
   PubMed Web of Science ®Google Scholar
• Karthikeyan C, Narayana Moorthy NSH, Ramasamy S, Vanam U, Manivannan E, Karunagaran D, Trivedi P. 2015. Advancer in chalcones with anticancer activities. Recent Pat Anticancer Drug Discov. 10(1):97–115.
   PubMed Web of Science ®Google Scholar
• Kłósek M, Mertas A, Król W, Jaworska D, Szymszal J, Szliszka E. 2016. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells after treatment with xanthohumol—A natural compound present in Humulus lupulus L. Int J Mol Sci. 17(6):837.
   PubMed Web of Science ®Google Scholar
• Komoto TT, Bernardes TM, Mesquita TB, Bortolotto LFB, Silva G, Bitencourt TA, Baek SJ, Marins M, Fachin AL. 2018. Chalcones repressed the AURKA and MDR proteins involved in metastasis and multiple drug resistance in breast cancer cell lines. Molecules. 23(8). doi:10.3390/molecules23082018.
   PubMed Web of Science ®Google Scholar
• Kong W, Li C, Qi Q, Shen J, Chang K. 2020. Cardamonin induces G2/M arrest and apoptosis via activation of the JNK–FOXO3a pathway in breast cancer cells. Cell Biol Int. 44(1):177–188.
   PubMed Web of Science ®Google Scholar
• Li X, Pham V, Tippin M, Fu D, Rendon R, Song L, Uchio E, Hoang BH, Zi X. 2019. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation. Cell Commun Signal. 17(1):1–13.
   PubMed Web of Science ®Google Scholar
• Li L, Tang P, Li S, Qin X, Yang H, Wu C, Liu Y. 2017. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy. Med Oncol. 34(10):180. doi:10.1007/s12032-017-1039-6.
   Web of Science ®Google Scholar
• Li J, Zheng L, Yan M, Wu J, Liu Y, Tian X, Jiang W, Zhang L, Wang R. 2020. Activity and mechanism of flavokawain A in inhibiting P-glycoprotein expression in paclitaxel resistance of lung cancer. Oncol Lett. 19(1):379–387.
   PubMed Web of Science ®Google Scholar
• Limper C, Wang Y, Ruhl S, Wang Z, Lou Y, Totzke F, Kubbutat MHG, Chovolou Y, Proksch P, Wätjen W. 2013. Compounds isolated from Psoralea corylifolia seeds inhibit protein kinase activity and induce apoptotic cell death in mammalian cells. J Pharm Pharmacol. 65(9):1393–1408.
   PubMed Web of Science ®Google Scholar
• Liu M, Yin H, Qian X, Dong J, Qian Z, Miao J. 2017. Xanthohumol, a prenylated chalcone from hops, inhibits the viability and stemness of doxorubicin-resistant MCF-7/ADR Cells. Molecules. 22(1):1–12.
   Web of Science ®Google Scholar
• Liu L, Zhang L, Zhao S, Zhao XY, Min PX, Ma YD, Wang YY, Chen Y, Tang SJ, Zhang YJ, et al. 2019. Non-canonical notch signaling regulates actin remodeling in cell migration by activating PI3K/AKT/Cdc42 pathway. Front Pharmacol. 10:370.
   PubMed Web of Science ®Google Scholar
• Ma L, Liu L, Ma Y, Xie H, Yu X, Wang X, Fan A, Ge D, Xu Y, Zhang Q, et al. 2017. The role of E-cadherin/β-Catenin in hydroxysafflor yellow A inhibiting adhesion, invasion, migration and lung metastasis of hepatoma cells. Biol Pharm Bull. 40(10):1706–1715.
   PubMed Web of Science ®Google Scholar
• Ma Y, Xu B, Yu J, Huang L, Zeng X, Shen X, Ren C, Ben-David Y, Luo H. 2020. Fli-1 activation through targeted promoter activity regulation using a novel 3’, 5’-diprenylated chalcone inhibits growth and metastasis of prostate cancer cells. Int J Mol Sci. 21(6):2216.
   PubMed Web of Science ®Google Scholar
• Mahapatra DK, Asati V, Bharti SK. 2019. An updated patent review of therapeutic applications of chalcone derivatives (2014-present). Expert Opin Ther Pat. 29(5):385–406.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation. Nature. 454(7203):436–444.
   PubMed Web of Science ®Google Scholar
• Nawaz J, Rasul A, Shah MA, Hussain G, Riaz A, Sarfraz I, Zafar S, Adnan M, Khan AH, Selamoglu Z. 2020. Cardamonin: a new player to fight cancer via multiple cancer signaling pathways. Life Sci. 250:117591.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. 2020. Natural Products as sources of new drugs over the nerly four decades from 01/1981 to 09/2019. J Nat Prod. 83(3):770–803.
   PubMed Web of Science ®Google Scholar
• Nuti E, Bassani B, Camodeca C, Rosalia L, Cantelmo AR, Gallo C, Baci D, Bruno A, Orlandini E, Nencetti S, et al. 2017. Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues. Eur J Med Chem. 138:890–899.
   PubMed Web of Science ®Google Scholar
• Padmavathi G, Roy NK, Bordoloi D, Arfuso F, Mishra S, Sethi G, Bishayee A, Kunnumakkara AB. 2017. Butein in health and disease: a comprehensive review. Phytomedicine. 25:118–127.
   PubMed Web of Science ®Google Scholar
• Park MK, Ji J, Haam K, Han TH, Lim S, Kang MJ, Lim SS, Ban HS. 2021. Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells. Biomed Pharmacother. 133:111082.
   PubMed Web of Science ®Google Scholar
• Park CR, Lee JS, Son CG, Lee NH. 2021. A survey of herbal medicines as tumor microenvironment-modulating agents. Phytother Res. 35(1):78–94.
   PubMed Web of Science ®Google Scholar
• Patel NK, Jaiswal G, Bhutani KK. 2016. A review on biological sources, chemistry and pharmacological activities of pinostrobin. Nat Prod Res. 30(18):2017–2027.
   PubMed Web of Science ®Google Scholar
• Primo LMF, Teixeira LK. 2020. Dna replication stress: oncogenes in the spotlight. Genet Mol Biol. 43(1):1–14.
   Web of Science ®Google Scholar
• Rani A, Anand A, Kumar K, Kumar V. 2019. Recent developments in biological aspects of chalcones: the odyssey continues. Expert Opin Drug Discov. 14(3):249–288.
   PubMed Web of Science ®Google Scholar
• Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. 2018. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 18(7):452–464. doi:10.1038/s41568-018-0005-8.
   PubMed Web of Science ®Google Scholar
• Rossette MC, Moraes DC, Sacramento EK, Romano-Silva MA, Carvalho JL, Gomes DA, Caldas H, Friedman E, Bastos-Rodrigues L, De Marco L. 2017. The in vitro and in vivo antiangiogenic effects of flavokawain B. Phytother Res. 31(10):1607–1613.
   PubMed Web of Science ®Google Scholar
• Sahu NK, Balbhadra SS, Choudhary J, Kohli DV. 2012. Exploring pharmacological significance of chalcone scaffold: A review. Curr Med Chem. 19(2):209–225.
   PubMed Web of Science ®Google Scholar
• Saito K, Matsuo Y, Imafuji H, Okubo T, Maeda Y, Sato T, Shamoto T, Tsuboi K, Morimoto M, Takahashi H, et al. 2018. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer. Cancer Sci. 109(1):132–140.
   PubMed Web of Science ®Google Scholar
• Salehi B, Quispe C, Chamkhi I, El Omari N, Balahbib A, Sharifi-Rad J, Bouyahya A, Akram M, Iqbal M, Docea AO, et al. 2020. Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence. Front Pharmacol. 11:592654. doi:10.3389/fphar.2020.592654.
   PubMed Web of Science ®Google Scholar
• Seitz T, Hackl C, Freese K, Dietrich P, Mahli A, Thasler RM, Thasler WE, Lang SA, Bosserhoff AK, Hellerbrand C. 2021. Xanthohumol, a prenylated chalcone derived from hops, inhibits growth and metastasis of melanoma cells. Cancers (Basel). 13(3):1–12.
   Web of Science ®Google Scholar
• Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. 2017. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 168(4):707–723.
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Jeengar MK, Thummuri D, Koval A, Katanaev VL, Marepally S, Naidu VGM. 2017. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Biofactors. 43(2):152–169.
   PubMed Web of Science ®Google Scholar
• Singh N, Baby D, Rajguru J, Patil P, Thakkannavar S, Pujari V. 2019. Inflammation and cancer. Ann Afr Med. 18(3):121–126.
   PubMed Web of Science ®Google Scholar
• Song XD, Wang YN, Zhang AL, Liu B. 2019. Advances in research on the interaction between inflammation and cancer. J Int Med Res. 48(4). doi:0300060519895347.
   Google Scholar
• Srinivasan B, Johnson TE, Lad R, Xing C. 2009. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. J Med Chem. 52(22):7228–7235.
   PubMed Web of Science ®Google Scholar
• Strasser A, Vaux DL. 2020. Cell death in the origin and treatment of cancer. Mol Cell. 78(6):1045–1054.
   PubMed Web of Science ®Google Scholar
• Suhail Y, Cain MP, Vanaja K, Kurywchak PA, Levchenko A, Kalluri R,K. 2019. Systems biology of cancer metastasis. Cell Syst. 9(2):109–127.
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhou C, Liu F, Zhang W, Chen J, Pan Y, Ma L, Liu Q, Du Y, Yang J, et al. 2018. Inhibition of breast cancer cell survival by Xanthohumol via modulation of the notch signaling pathway in vivo and in vitro. Oncol Lett. 15(1):908–916.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Tabata K, Motani K, Takayanagi N, Nishimura R, Asami S, Kimura Y, Ukiya M, Hasegawa D, Akihisa T, Suzuki T. 2005. Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells. Biol Pharm Bull. 28(8):1404–1407.
   PubMed Web of Science ®Google Scholar
• Tang ZH, Chen X, Wang ZY, Chai K, Wang YF, Xu XH, Wang XW, Lu JH, Wang YT, Chen XP, Lu JJ. 2016. Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cells. Sci Rep. 6(May):26210–26241.
   PubMedGoogle Scholar
• Ur Rashid H, Xu Y, Ahmad N, Muhammad Y, Wang L. 2019. Promising anti-inflammatory effects of chalcones via inhibition of cyclooxygenase, prostaglandin E2, inducible NO synthase and nuclear factor κb activities. Bioorg Chem. 87:335–365.
   PubMed Web of Science ®Google Scholar
• Ventura TLB, Calixto SD, De Azevedo Abrahim-Vieira B, De Souza AMT, Mello MVP, Rodrigues CR, De Mariz E, Miranda LS, De Souza ROMA, Leal ICR, Lasunskaia EB, et al. 2015. Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach. Molecules. 20(5):8072–8093.
   PubMed Web of Science ®Google Scholar
• Visconti R, Della Monica R, Grieco D. 2016. Cell cycle checkpoint in cancer: A therapeutically targetable double-edged sword. J Exp Clin Cancer Res. 35(1):1–8.
   PubMedGoogle Scholar
• Wang C, Chen Y, Wang Y, Liu X, Liu Y, Li Y, Chen H, Fan C, Wu D, Yang J. 2019. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1. J Exp Clin Cancer Res. 38(1):1–14.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liang X, Xiong A, Ding L, Li W, Yang L, Wu X, Shi H, Zhou Y, Wang Z. 2021. Helichrysetin and TNF-α synergistically promote apoptosis by inhibiting overactivation of the NF-κB and EGFR signaling pathways in HeLa and T98G cells. Int J Mol Med. 47(4):1–11.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang W, Wang Z, Gao M, Wang X, Han W, Zhang N, Xu X. 2020. Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism pathway. J Pharm Biomed Anal. 186:113288.
   PubMed Web of Science ®Google Scholar
• Washiyama M, Sasaki Y, Hosokawa T, Nagumo S. 2009. Anti-inflammatory constituents of sappan Lignum. Biol Pharm Bull. 32(5):941–944.
   PubMed Web of Science ®Google Scholar
• Wei S, Sun T, Du J, Zhang B, Xiang D, Li W. 2018. Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro. Oncol Rep. 40(6):3213–3222.
   PubMed Web of Science ®Google Scholar
• Wu CH, Chen HY, Wang CW, Shieh TM, Huang TC, Lin LC, Wang KL, Hsia SM. 2016. Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice. Oncotarget. 7(45):73432–73447.
   PubMedGoogle Scholar
• Wu J, Shun Jiang J, Chen B, Jun Wang K, Tang Y, Ling, Liang X. h. 2021. Plasticity of cancer cell invasion: Patterns and mechanisms. Transl Oncol. 14(1):100899.
   PubMed Web of Science ®Google Scholar
• Wu P, Yu T, Wu J, Chen J, Chen J. 2020. Licochalcone a induces ROS-mediated apoptosis through TrxR1 inactivation in colorectal cancer cells. Biomed Res Int. 2020:5875074.
   PubMed Web of Science ®Google Scholar
• Xia L, Tan S, Zhou Y, Lin J, Wang H, Oyang L, Tian Y, Liu L, Su M, Wang H, et al. 2018. Role of the NFκB-signaling pathway in cancer. Onco Targets Ther. 11:2063–2073.
   PubMed Web of Science ®Google Scholar
• Xiang S, Zeng H, Xia F, Ji Q, Xue J, Ren R, Que F, Zhou B. 2021. The dietary flavonoid isoliquiritigenin induced apoptosis and suppressed metastasis in melanoma cells: An in vitro and in vivo study. Life Sci. 264:118598.
   PubMed Web of Science ®Google Scholar
• Yang F, Li J, Zhu J, Wang D, Chen S, Bai X. 2015. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice. Eur J Pharmacol. 754:105–114.
   PubMed Web of Science ®Google Scholar
• Yuan LW, Jiang XM, Xu YL, Huang MY, Chen YC, Yu WB, Su MX, Ye ZH, Chen X, Wang Y, Lu JJ. 2021. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells. Phytomedicine. 80:153394.
   PubMed Web of Science ®Google Scholar
• Zhang B, Lai Y, Li Y, Shu N, Wang Z, Wang Y, Li Y, Chen Z. 2018. Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis. Eur J Pharmacol. 821:57–67.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li J, Song H, Xiong Y, Liu D, Bai X. 2019. Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation. Biomed Pharmacother. 109:806–814.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang M, Teng S, Wang D, Li X, Wang X, Liao W, Wang D. 2018. Indolyl-chalcone derivatives induce hepatocellular carcinoma cells apoptosis through oxidative stress related mitochondrial pathway in vitro and in vivo. Chem Biol Interact. 293:61–69.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z. 2017. Chalcone: a privileged structure in medicinal chemistry. Chem Rev. 117(12):7762–7810.
   PubMed Web of Science ®Google Scholar